Vetanco International Acknowledgment for Sherry Layton, Vetanco Scientific Director

Sherry Layton, Vetanco Scientific Director, will be awarded in the 12th International Conference on Emerging Infectious Diseases

Sherry Layton - Chief Executive Officer - Vetanco USA

Vetanco Kenya and Ghana exhibitions - Vetanco

PDF) Evaluation of a subunit vaccine candidate (Biotech Vac Cox) against Eimeria spp. in broiler chickens

Vetanco Sherry Layton, Vetanco USA Inc. CSO, was invited to give a presentation at Vaccines 2020 - Vetanco

Vetanco International Acknowledgment for Sherry Layton, Vetanco Scientific Director

Vetanco Sherry Layton, Vetanco USA Inc. CSO, was invited to give a presentation at Vaccines 2020 - Vetanco

New Trends in Vaccine Development

News - BV Science

Frontiers Evaluation of a Novel Mucosal Administered Subunit Vaccine on Colostrum IgA and Serum IgG in Sows and Control of Enterotoxigenic Escherichia coli in Neonatal and Weanling Piglets: Proof of Concept

PDF) Evaluation of a subunit vaccine candidate (Biotech Vac Cox) against Eimeria spp. in broiler chickens

Frontiers Development of the Tonsil Microbiome in Pigs and Effects of Stress on the Microbiome

Vetanco Vetanco's presence at the Latin American Scientific Conference

New Trends in Vaccine Development

PDF) Pathogenesis, Molecular Genetics, and Genomics of Mycobacterium avium subsp. paratuberculosis, the Etiologic Agent of Johne's Disease

PDF) Strategies for Enhancing the Effectiveness of Metagenomic-based Enzyme Discovery in Lignocellulolytic Microbial Communities